National Cancer Institute Home at the National Institutes of Health |
Please wait while this form is being loaded....
The Applied Research Program Web site is no longer maintained. ARP's former staff have moved to the new Healthcare Delivery Research Program, the Behavioral Research Program, or the Epidemiology & Genetics Research Program, and the content from this Web site is being moved to one of those sites as appropriate. Please update your links and bookmarks!

Publication Abstract

Authors: Stock C, Knudsen AB, Lansdorp-Vogelaar I, Haug U, Brenner H

Title: Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy.

Journal: Gastrointest Endosc 73(3):435-443.e5

Date: 2011 Mar

Abstract: BACKGROUND: Use of colonoscopy is thought to reduce colorectal cancer (CRC) mortality, but its impact at the population level is unclear. OBJECTIVE: To estimate the effect of current colonoscopy use on CRC mortality and its further potential in reducing CRC mortality. DESIGN: Population-level analysis was performed by using the concepts of prevented and attributable fractions, by using data from the National Health Interview Survey, the Surveillance, Epidemiology and End Results Program, and estimates of the effectiveness of colonoscopy at reducing CRC mortality. SETTING: The 2005 U.S. population aged 50 years and older. EXPOSURE: Colonoscopy within 10 years or less. MAIN OUTCOME MEASUREMENTS: Percentages and absolute numbers of CRC deaths prevented and potentially preventable by colonoscopy. LIMITATIONS: Uncertainty in effectiveness estimates. RESULTS: Overall, the proportions of CRC deaths in 2005 prevented by colonoscopy (ie, the prevented fractions) range from 13% (95% CI, 11%-15%) to 19% (95% CI, 12%-24%) across the estimates of colonoscopy effectiveness. Corresponding numbers of CRC deaths prevented range from 7314 (95% CI, 6010-8467) to 11,711 (95% CI, 7077-14,898). The proportions of CRC deaths attributable to nonuse of colonoscopy (ie, the attributable fractions) range from 28% (95% CI, 22%-33%) to 44% (95% CI, 24%-60%), depending on the assumed effectiveness. Corresponding numbers of CRC deaths attributed to nonuse of colonoscopy range from 13,796 (95% CI, 11,076-16,255) to 22,088 (95% CI, 12,189-29,947). CONCLUSIONS: Although we estimate that colonoscopy has prevented substantial numbers of CRC deaths, many more deaths could have been prevented with more widespread use. These findings highlight the potential benefits from public health interventions to increase the use of screening colonoscopy.

Last Modified: 03 Sep 2013